Abstract
Thiopurine S-methyltransferase (TPMT) is a biotransformation phase II enzyme responsible for the metabolic inactivation of thiopurine drugs. The present study was carried out to investigate the inhibitory potential of 15 nonsteroidal anti-inflammatory drugs (NSAIDs) on human TPMT activity in vitro. TPMT activity was measured in pooled human erythrocytes in the absence and presence of various NSAIDs using the previously published high-performance liquid chromatography-UV method. To determine the inhibition type and Ki value for each compound, we performed kinetic analysis at five different inhibitor concentrations close to the IC50 value obtained in preliminary experiments. Naproxen (Ki = 52 μM), mefenamic acid (Ki = 39 μM), and tolfenamic acid (Ki = 50 μM) inhibited TPMT activity in a noncompetitive manner. The estimated Ki values for the inhibition of TPMT by ketoprofen (Ki = 172 μM) and ibuprofen (Ki = 1043 μM) indicated that the propionic acid derivatives were relatively weak inhibitors of TPMT. Our results suggest that coadministration of thiopurines and various NSAIDs may lead to drug interactions.
Footnotes
-
This study was financially supported by the Estonian Science Foundation Grant 6691.
-
doi:10.1124/dmd.107.016287.
-
ABBREVIATIONS: TPMT, thiopurine S-methyltransferase; RBC, red blood cells; 6-MP, 6-mercaptopurine; 6-MMP, 6-methylmercaptopurine; DMSO, dimethyl sulfoxide; IC50, inhibitor concentration required to inhibit enzyme activity by 50%; V, enzyme activity; Imax, maximum inhibition effect.
- Received April 16, 2007.
- Accepted June 5, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|